Annual report
6856.TEDINET S100T3YZ
Period2023-01-01 → 2023-12-31
Filed2024-03-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥290.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥270.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥224.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥187.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥200.2bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥47.3bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥45.8bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥48.3bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥46.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥32.0bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥19.4bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20.5bn | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥53.7bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥47.3bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥40.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.3bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥13.2bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥15.5bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥40.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥449.0bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥416.7bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥371.6bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥328.1bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥315.1bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥165.3bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥175.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥283.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥240.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥204.5bn | at 2021-12-31d | Cons. | Net assets |
| Net assets / equity | ¥178.7bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥171.6bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥132.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥139.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥130.6bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥138.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥133.9bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥114.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥96.1bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥16.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥34.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥32.3bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥26.6bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥7.3bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.7bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.7bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14.0bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥12.4bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥21.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥22.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥843m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥19.2bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥953.71 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥807.06 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥505.05 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥312.58 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥367.09 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥948.83 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥802.89 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥502.46 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥311.09 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥365.44 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥6,695.3 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,684.68 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,827.06 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,217.45 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,053.3 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 63.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.8% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.3% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.3% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 15.4% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.4% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 8,665 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 8,432 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 8,205 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 8,269 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 8,288 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥54.6bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥51.9bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥50.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥50.1bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥64.0bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥5.2bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥3.8bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥24.0bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥16.0bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.7bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.2bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.7bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥23.9bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥15.8bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | ¥22.7bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥14.6bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥1.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥11.8bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥224.6bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥223.0bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥221.8bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥214.2bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥207.5bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥90.5bn | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥103.4bn | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥134.1bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥119.7bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥113.2bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥114.7bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥111.9bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥37.8bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥52.9bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥537.92 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥344.94 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.03 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.02 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥280.18 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥535.17 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥343.16 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.8 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥171.2 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥278.92 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥290 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥245 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥130 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,156.37 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,815.8 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,664.43 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,700.73 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,638.66 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 59.4% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.3% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.2% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 18.0% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.6% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.0% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 42,532,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,510 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 1,484 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 1,542 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 1,623 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 1,702 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 72
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥151.3bn |
| Automotivereportable segment | capex | 2023-01-01 → 2023-12-31 | ¥4.1bn |
| Automotivereportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥4.5bn |
| Automotivereportable segment | employees | at 2023-12-31 | 2611 pure |
| Automotivereportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥80.4bn |
| Automotivereportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥80.4bn |
| Automotivereportable segment | segment assets | at 2023-12-31 | ¥103.8bn |
| Automotivereportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.2bn |
| Medical Diagnosticreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥1.2bn |
| Medical Diagnosticreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥2.1bn |
| Medical Diagnosticreportable segment | employees | at 2023-12-31 | 1197 pure |
| Medical Diagnosticreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥32.7bn |
| Medical Diagnosticreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥32.7bn |
| Medical Diagnosticreportable segment | segment assets | at 2023-12-31 | ¥30.9bn |
| Medical Diagnosticreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥638m |
| Process And Environmentalreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥548m |
| Process And Environmentalreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥819m |
| Process And Environmentalreportable segment | employees | at 2023-12-31 | 677 pure |
| Process And Environmentalreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥25.0bn |
| Process And Environmentalreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥25.0bn |
| Process And Environmentalreportable segment | segment assets | at 2023-12-31 | ¥23.5bn |
| Process And Environmentalreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.4bn |
| Scientificreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥986m |
| Scientificreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥1.5bn |
| Scientificreportable segment | employees | at 2023-12-31 | 1071 pure |
| Scientificreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥39.6bn |
| Scientificreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥39.6bn |
| Scientificreportable segment | segment assets | at 2023-12-31 | ¥37.0bn |
| Scientificreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.5bn |
| Semiconductorreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥2.3bn |
| Semiconductorreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥3.2bn |
| Semiconductorreportable segment | employees | at 2023-12-31 | 1326 pure |
| Semiconductorreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥112.9bn |
| Semiconductorreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥112.9bn |
| Semiconductorreportable segment | segment assets | at 2023-12-31 | ¥102.5bn |
| Semiconductorreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥40.6bn |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥155.6bn |
| Automotivereportable segment | capex | 2022-01-01 → 2022-12-31 | ¥5.5bn |
| Automotivereportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥3.9bn |
| Automotivereportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥67.5bn |
| Automotivereportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥67.5bn |
| Automotivereportable segment | segment assets | at 2022-12-31 | ¥84.2bn |
| Automotivereportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥667m |
| Medical Diagnosticreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥1.6bn |
| Medical Diagnosticreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥2.0bn |
| Medical Diagnosticreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥29.8bn |
| Medical Diagnosticreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥29.8bn |
| Medical Diagnosticreportable segment | segment assets | at 2022-12-31 | ¥28.5bn |
| Medical Diagnosticreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥99m |
| Process And Environmentalreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥829m |
| Process And Environmentalreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥727m |
| Process And Environmentalreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥22.5bn |
| Process And Environmentalreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥22.5bn |
| Process And Environmentalreportable segment | segment assets | at 2022-12-31 | ¥19.7bn |
| Process And Environmentalreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥2.1bn |
| Scientificreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥1.3bn |
| Scientificreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥1.2bn |
| Scientificreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥36.2bn |
| Scientificreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥36.2bn |
| Scientificreportable segment | segment assets | at 2022-12-31 | ¥31.2bn |
| Scientificreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥2.5bn |
| Semiconductorreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥3.3bn |
| Semiconductorreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥3.0bn |
| Semiconductorreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥114.1bn |
| Semiconductorreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥114.1bn |
| Semiconductorreportable segment | segment assets | at 2022-12-31 | ¥97.5bn |
| Semiconductorreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥42.0bn |
| Automotivereportable segment | employees | at 2023-12-31 | 364 pure |
| Medical Diagnosticreportable segment | employees | at 2023-12-31 | 142 pure |
| Process And Environmentalreportable segment | employees | at 2023-12-31 | 150 pure |
| Scientificreportable segment | employees | at 2023-12-31 | 126 pure |
| Semiconductorreportable segment | employees | at 2023-12-31 | 31 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,775
| Item | Context | Value | Unit |
|---|---|---|---|
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | Original text (Japanese)取引先持株会での定期買付によるものです。 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)日本新薬株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)トヨタ自動車株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)ニデック株式会社（注）２ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)フクダ電子株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)ローム株式会社（注）３ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)株式会社SCREENホールディングス（注）４ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)株式会社ワコールホールディングス | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)株式会社京都フィナンシャルグループ（注）５ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)小野薬品工業株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)株式会社三菱UFJフィナンシャル・グループ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)TOWA株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)株式会社中央倉庫 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Original text (Japanese)本田技研工業株式会社（注）６ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row14Member | Original text (Japanese)イビデン株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row14Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row14Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row15Member | Original text (Japanese)株式会社日立製作所 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row15Member | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |